Thus, the Examples of the present application demonstrate that established genes and signaling pathways that confer tamoxifen resistance and possibly other forms of endocrine therapy resistance do so by acting on eIF4E abundance and phosphorylation to selectively translationally reprogram the breast cancer cell for estrogen and ER opposing activities <a href=http://doxycycline.world/>side effects doxycycline monohydrate</a> |
|